| scholarly article | Q13442814 |
| P2093 | author name string | Yan Jiang | |
| Wei Liang | |||
| Xiuli Zhang | |||
| Dan Liang | |||
| Hui He | |||
| Zhi-Hong Chi | |||
| Jianfei Ma | |||
| P2860 | cites work | Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. | Q52189547 |
| Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system | Q74326554 | ||
| Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy | Q79301271 | ||
| Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients | Q80174559 | ||
| Antroquinonol reduces oxidative stress by enhancing the Nrf2 signaling pathway and inhibits inflammation and sclerosis in focal segmental glomerulosclerosis mice | Q83534455 | ||
| Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy | Q39651292 | ||
| Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression | Q39818094 | ||
| Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease | Q39960465 | ||
| Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator | Q40412944 | ||
| Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. | Q40464612 | ||
| Transforming growth factor beta in diabetic nephropathy | Q41333770 | ||
| Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl₄-intoxicated mice is mediated by suppression of oxidative stress and upregulation of MMP-2 expression | Q42158636 | ||
| Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice | Q42165757 | ||
| Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2. | Q42480067 | ||
| A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. | Q42486098 | ||
| Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study | Q42712338 | ||
| Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats | Q42752177 | ||
| Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice. | Q42936581 | ||
| Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury | Q43071829 | ||
| Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure | Q43223381 | ||
| Zinc transporter 5 and zinc transporter 7 induced by high glucose protects peritoneal mesothelial cells from undergoing apoptosis | Q43963197 | ||
| Berberine suppresses high glucose-induced TGF-β1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway | Q44036628 | ||
| Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis. | Q44773514 | ||
| The transcription factor NRF2 protects against pulmonary fibrosis | Q44945397 | ||
| Inhibition of TGF-β1-receptor posttranslational core fucosylation attenuates rat renal interstitial fibrosis | Q45235054 | ||
| Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition | Q46163975 | ||
| Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice. | Q46193503 | ||
| Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling | Q46480430 | ||
| Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors | Q46921370 | ||
| Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. | Q47586979 | ||
| Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans | Q47957732 | ||
| TGF-beta signal transduction | Q22003891 | ||
| Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes | Q24170228 | ||
| The pathogenic role of the renal proximal tubular cell in diabetic nephropathy | Q27021593 | ||
| Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE) | Q28366662 | ||
| Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway | Q28573256 | ||
| Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion | Q28578447 | ||
| The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy | Q33750711 | ||
| The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? | Q33778918 | ||
| Bardoxolone methyl and kidney function in CKD with type 2 diabetes | Q34194954 | ||
| Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. | Q34214639 | ||
| Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models | Q34399505 | ||
| Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling | Q34441024 | ||
| Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury | Q34572978 | ||
| Combating diabetic nephropathy with drug therapy | Q35087369 | ||
| Reactive oxygen species and matrix remodeling in diabetic kidney | Q35182366 | ||
| Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy | Q35404877 | ||
| Retracted: Berberine Improves Kidney Function in Diabetic Mice via AMPK Activation | Q35436194 | ||
| Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? | Q36188436 | ||
| The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis | Q36652097 | ||
| Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways | Q36690275 | ||
| Phenotypic transitions and fibrosis in diabetic nephropathy | Q36753326 | ||
| Rodent models of streptozotocin-induced diabetic nephropathy | Q36820026 | ||
| Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis | Q36842403 | ||
| The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice | Q37513209 | ||
| TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. | Q37627056 | ||
| Effect of zinc on high glucose-induced epithelial-to-mesenchymal transition in renal tubular epithelial cells | Q38887463 | ||
| Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway | Q39048243 | ||
| Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth. | Q39108936 | ||
| Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells | Q39370584 | ||
| Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling | Q39431057 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2016-08-12 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice | |
| P478 | volume | 17 |
| Q64093257 | Berberine Protects Glomerular Podocytes via Inhibiting Drp1-Mediated Mitochondrial Fission and Dysfunction |
| Q55108878 | Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway. |
| Q33819605 | Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities |
| Q37741992 | Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice |
| Q59125948 | Hyperglycemia activates the renin-angiotensin system and induces epithelial-mesenchymal transition in streptozotocin-induced diabetic kidneys |
| Q48096965 | Modulation of heme oxygenase-1 expression and activity affects streptozotocin-induced diabetic nephropathy in rats. |
| Q92869440 | Nrf2 signaling attenuates epithelial-to-mesenchymal transition and renal interstitial fibrosis via PI3K/Akt signaling pathways |
| Q91595151 | Podoplanin mediates the renoprotective effect of berberine on diabetic kidney disease in mice |
| Q92510491 | Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review |
| Q33645497 | Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy |
| Q94950021 | Therapeutic Application of Nutraceuticals in Diabetic Nephropathy: Current Evidence and Future Implications |
| Q60932209 | Therapeutic potential of thymoquinone liposomes against the systemic infection of Candida albicans in diabetic mice |
Search more.